Case number 2018-1062
Reckitt Benckiser Pharm. v. Watson Laboratories Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 19, 2019 | 36 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [629159] [17-2587, 18-1010, 18-1058, 18-1062, 18-1114, 18-1115, 18-1176, 18-1177] [JAB] [Entered: 08/19/2019 10:03 AM] (2) |
| Jul 12, 2019 | 35 | JUDGMENT. AFFIRMED-IN-PART, VACATED-IN-PART. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [620516] [17-2587, 18-1010, 18-1058, 18-1062, 18-1114, 18-1115, 18-1176, 18-1177] [JAB] [Entered: 07/12/2019 10:18 AM] (2) |
| Jul 12, 2019 | 34 | OPINION filed for the court by Newman, Circuit Judge; Mayer, Circuit Judge and Lourie, Circuit Judge. Dissenting opinion filed by Circuit Judge Mayer. Precedential Opinion. [620514] [17-2587, 18-1010, 18-1058, 18-1062, 18-1114, 18-1115, 18-1176, 18-1177, 18-1949, 18-2045] [JAB] [Entered: 07/12/2019 10:17 AM] (51) |
| Jun 8, 2018 | 33 | Note to file: The following cases are consolidated: 17-2587 (Lead) with 18-1010, -1058, -1062, -1114, -1115, -1176, -1177 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [528113] [17-2587, 18-1010, 18-1058, 18-1062, 18-1114, 18-1115, 18-1176, 18-1177] [MJL] [Entered: 06/08/2018 03:55 PM] (0) |
| Jun 8, 2018 | 32 | ORDER filed. The motion to dismiss appeals 16-2277, 16-2278, 16-2397, 16-2398, 18-1061, and 18-1119 pursuant to FRAP 42(b) [524838-2] is granted and the mandate is issued. The revised official caption for 17-2587, 18-1010, -1058, -1062, -1114, -1115, -1176, -1177 is reflected in the order. - FOR CALENDAR. Service as of this date by the Clerk of Court. [528099] [16-2277, 16-2278, 16-2397, 16-2398, 18-1061, 18-1119, 17-2587, 18-1010, 18-1058, 18-1062, 18-1114, 18-1115, 18-1176, 18-1177] [MJL] [Entered: 06/08/2018 03:35 PM] (4) |
| Nov 1, 2017 | 31 | Note to file: The following cases are consolidated:16-2277 (Lead) with 16-2278, 16-2397, 16-2398, 17-2587, 18-1010, 18-1058, 18-1061, 18-1062, 18-1114, 18-1115, 18-1119 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [472364] [JB] [Entered: 11/01/2017 04:22 PM] (0) |
| Nov 1, 2017 | 30 | ORDER consolidating appeals (16-2277 (Lead) with 16-2278, 16-2397, 16-2398, 17-2587, 18-1010, 18-1058, 18-1061, 18-1062, 18-1114, 18-1115, 18-1119 (Members)). These appeals are consolidated. The revised official caption is reflected above. The appeallants' opening briefs are due no late than December 15, 2017. Service as of this date by Clerk of Court. [472356] [JB] [Entered: 11/01/2017 04:07 PM] (2) |
| Oct 30, 2017 | 8 | Entry of appearance for Stephen R. Smerek as of counsel for Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471330] [Stephen Smerek] [Entered: 10/30/2017 11:21 AM] (2) |
| Oct 30, 2017 | 9 | Docketing Statement for the Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471362] [George Lombardi] [Entered: 10/30/2017 12:18 PM] (3) |
| Oct 30, 2017 | 10 | Certificate of Interest for the Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471365] [George Lombardi] [Entered: 10/30/2017 12:20 PM] (5) |
| Oct 30, 2017 | 11 | Entry of appearance for Erica N. Andersen as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471567] [Erica Andersen] [Entered: 10/30/2017 05:20 PM] (2) |
| Oct 30, 2017 | 12 | Entry of appearance for Beth S. Brinkmann as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471568] [Erica Andersen] [Entered: 10/30/2017 05:21 PM] (2) |
| Oct 30, 2017 | 13 | Entry of appearance for R. Jason Fowler as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471569] [Erica Andersen] [Entered: 10/30/2017 05:21 PM] (2) |
| Oct 30, 2017 | 14 | Entry of appearance for Jeffrey B. Elikan as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471570] [Erica Andersen] [Entered: 10/30/2017 05:22 PM] (2) |
| Oct 30, 2017 | 15 | Entry of appearance for Jeffrey H. Lerner as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471571] [Erica Andersen] [Entered: 10/30/2017 05:23 PM] (2) |
| Oct 30, 2017 | 16 | Entry of appearance for Matthew Kudzin as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email. [471573] [Erica Andersen] [Entered: 10/30/2017 05:23 PM] (2) |
| Oct 30, 2017 | 17 | Entry of appearance for James Francis Hibey as principal counsel for Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471606] [James Hibey] [Entered: 10/30/2017 06:09 PM] (2) |
| Oct 30, 2017 | 18 | Entry of appearance for Cassandra A. Adams as of counsel for Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471608] [Cassandra Adams] [Entered: 10/30/2017 06:11 PM] (2) |
| Oct 30, 2017 | 19 | Certificate of Interest for the Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471610] [Cassandra Adams] [Entered: 10/30/2017 06:12 PM] (3) |
| Oct 30, 2017 | 20 | Docketing Statement for the Appellant MonoSol Rx, LLC. Service: 10/30/2017 by email. [471611] [Cassandra Adams] [Entered: 10/30/2017 06:13 PM] (5) |
| Oct 30, 2017 | 21 | Entry of appearance for James M. Bollinger as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471614] [James Bollinger] [Entered: 10/30/2017 06:18 PM] (2) |
| Oct 30, 2017 | 22 | Entry of appearance for Charanjit Brahma as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471615] [Charanjit Brahma] [Entered: 10/30/2017 06:23 PM] (2) |
| Oct 30, 2017 | 23 | Entry of appearance for Timothy P. Heaton as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471621] [Timothy Heaton] [Entered: 10/30/2017 06:27 PM] (2) |
| Oct 30, 2017 | 24 | Entry of appearance for Magnus Essunger as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471622] [Magnus Essunger] [Entered: 10/30/2017 06:29 PM] (2) |
| Oct 30, 2017 | 25 | Entry of appearance for Dustin B. Weeks as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471624] [Dustin Weeks] [Entered: 10/30/2017 06:35 PM] (2) |
| Oct 30, 2017 | 26 | Entry of appearance for Gerald E. Porter as of counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471625] [Gerald Porter] [Entered: 10/30/2017 06:38 PM] (2) |
| Oct 30, 2017 | 27 | Certificate of Interest for the Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471633] [Timothy Heaton] [Entered: 10/30/2017 06:52 PM] (5) |
| Oct 30, 2017 | 28 | Docketing Statement for the Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by clerk. [471634] [Timothy Heaton] [Entered: 10/30/2017 06:54 PM] (6) |
| Oct 30, 2017 | 29 | Entry of appearance for Daniel A. Ladow as principal counsel for Appellant Reckitt Benckiser Pharmaceuticals Inc.. Service: 10/30/2017 by email, clerk. [471669] [Daniel Ladow] [Entered: 10/30/2017 07:58 PM] (2) |
| Oct 30, 2017 | 7 | Entry of appearance for Michael K. Nutter as of counsel for Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471328] [Michael Nutter] [Entered: 10/30/2017 11:18 AM] (2) |
| Oct 30, 2017 | 6 | Entry of appearance for Tyler G. Johannes as of counsel for Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471325] [Tyler Johannes] [Entered: 10/30/2017 11:15 AM] (2) |
| Oct 30, 2017 | 5 | Entry of appearance for Geoffrey P. Eaton as of counsel for Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471324] [Geoffrey Eaton] [Entered: 10/30/2017 11:11 AM] (2) |
| Oct 30, 2017 | 4 | Entry of appearance for George C. Lombardi as principal counsel for Cross-Appellants Actavis Laboratories UT, Inc. and Watson Laboratories Inc.. Service: 10/30/2017 by email. [471323] [George Lombardi] [Entered: 10/30/2017 11:08 AM] (2) |
| Oct 27, 2017 | 3 | Official caption revised add Cross-Appeal 18-1115. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [471172] [JB] [Entered: 10/27/2017 03:47 PM] (0) |
| Oct 27, 2017 | 2 | Note to file: The following cases are associated:18-1062 Lead with 18-1115 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [471169] [JB] [Entered: 10/27/2017 03:44 PM] (0) |
| Oct 16, 2017 | 1 | Appeal docketed. Received: 10/16/2017. [468128]Entry of Appearance due 10/30/2017. Certificate of Interest is due on 10/30/2017. Docketing Statement due 10/30/2017. Appellant/Petitioner's brief is due 12/15/2017. [JB] [Entered: 10/16/2017 03:21 PM] (33) |
